Prospects for the future of epidermal growth factor receptor-tyrosine kinase inhibitors in combination with bevacizumab

被引：1
作者：
Chikaishi, Yasuhiro [1 ,2 ]
Tanaka, Fumihiro [2 ]
Honda, Yohei [1 ]
Inoue, Masaaki [1 ]
Yoshida, Junichi [1 ]
Tanaka, Masao [1 ]
机构：
[1] Shimonoseki City Hosp, Dept Chest Surg, 1-13-1 Kouyouchou, Shimonoseki, Yamaguchi 7508520, Japan
[2] Univ Occupat & Environm Hlth, Sch Med, Dept Surg 2, Yahatanishi Ku, Kitakyushu, Fukuoka, Japan
来源：
TRANSLATIONAL CANCER RESEARCH | 2020年 / 9卷 / 03期
关键词：
CELL LUNG-CANCER; EGFR MUTATIONS; OPEN-LABEL; CHEMOTHERAPY; ADENOCARCINOMA; OSIMERTINIB; MULTICENTER; GEFITINIB; ERLOTINIB; SURVIVAL;
D O I：
10.21037/tcr.2020.01.24
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1307 / 1310
页数：4
相关论文
共 24 条
  • [21] Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer
    Togashi, Yosuke
    Masago, Katsuhiro
    Masuda, Satohiro
    Mizuno, Tomoyuki
    Fukudo, Masahide
    Ikemi, Yasuaki
    Sakamori, Yuichi
    Nagai, Hiroki
    Kim, Young Hak
    Katsura, Toshiya
    Mishima, Michiaki
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (03) : 399 - 405
  • [22] Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
    Yang, James Chih-Hsin
    Wu, Yi-Long
    Schuler, Martin
    Sebastian, Martin
    Popat, Sanjay
    Yamamoto, Nobuyuki
    Zhou, Caicun
    Hu, Cheng-Ping
    O'Byrne, Kenneth
    Feng, Jifeng
    Lu, Shun
    Huang, Yunchao
    Geater, Sarayut L.
    Lee, Kye Young
    Tsai, Chun-Ming
    Gorbunova, Vera
    Hirsh, Vera
    Bennouna, Jaafar
    Orlov, Sergey
    Mok, Tony
    Boyer, Michael
    Su, Wu-Chou
    Lee, Ki Hyeong
    Kato, Terufumi
    Massey, Dan
    Shahidi, Mehdi
    Zazulina, Victoria
    Sequist, Lecia V.
    [J]. LANCET ONCOLOGY, 2015, 16 (02) : 141 - 151
  • [23] Yano S, 2000, CLIN CANCER RES, V6, P957
  • [24] Yoneda Kazue, 2018, Journal of UOEH, V40, P173, DOI 10.7888/juoeh.40.173
123